N-Cyclopropyl-2-(piperazin-1-yl)acetamide

Catalog No. :
ACQLKW140
CAS No. :
847783-37-3
Molecular Formula :
C9H17N3O
Molecular Weight :
183.26

IUPAC Name:N-cyclopropyl-2-(piperazin-1-yl)acetamide

N-Cyclopropyl-2-(piperazin-1-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$155.00Login to see priceInquiryInquiry
250mg95%$233.00Login to see priceInquiryInquiry
1g95%$543.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Cyclopropyl-2-(piperazin-1-yl)acetamide
IUPAC NameN-cyclopropyl-2-(piperazin-1-yl)acetamide
Molecular FormulaC9H17N3O
Molecular Weight183.26
SMILESO=C(NC1CC1)CN2CCNCC2
InChI KeyPSGKMZFJVPGLJH-UHFFFAOYSA-N
SynonymN-cyclopropyl-2-(1-piperazinyl)acetamide(SALTDATA: HCl);N-cyclopropyl-2-(1-piperazinyl)acetamide;N-cyclopropyl-2-piperazin-1-yl-ethanamide;2-(4-cyclopropylpiperazin-1-yl)acetamide;1-Piperazineacetamide, N-cyclopropyl-;N-Cyclopropyl-2-(piperazin-1-yl)acetamide hydrochloride;N-Cyclopropyl-2-piperazin-1-yl-ac
CAS No.847783-37-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P305+P351+P338-P337+P313-P501

Synthetic Route by SureRoute

1. ACQLKW140 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBRWP053 route compound structure diagram
    ACBRWP05357260-72-7 In Stock
  2. Plus
  3. ACNQUT007 route compound structure diagram
    ACNQUT00718600-39-0 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACQLKW140 route product structure diagram
    ACQLKW140847783-37-3
Inquiry

2. ACQLKW140 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACQLKW140 route product structure diagram
    ACQLKW140847783-37-3
Inquiry

Comments (0)